30 Participants Needed

Ketogenic vs Mediterranean Diets for Aging

CB
SB
Overseen BySanaa Badour, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Florida
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Preclinical data indicate that very low carbohydrate ketogenic diets (KD) may prevent progression of age-related sarcopenia (skeletal muscle decline) but also may disturb bone metabolism. The investigators will pilot test a randomized trial comparing the effects of short-term adaptation to a well-formulated ketogenic diet and Mediterranean diet on markers of bone metabolism and muscle function in older adults. The expected results will help inform the benefit-risk assessment for older patients considering longer term use of KD therapy.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you are on anti-hypertensive medication, you may still be eligible to participate.

What data supports the effectiveness of the treatment Mediterranean Diet, MedDiet, Mediterranean-style diet, Very Low Carbohydrate Ketogenic Diet, Ketogenic Diet, Very Low Carbohydrate Diet, Low-Carb High-Fat Diet?

Research shows that the Mediterranean diet can reduce hospital stays, lower medical costs, and decrease mortality in older adults. The ketogenic diet has been beneficial for weight loss, diabetes control, and cancer outcomes in older patients, although it may cause some side effects like constipation and fatigue.12345

Is the Mediterranean diet generally safe for humans?

Research suggests that the Mediterranean diet is generally safe and may even reduce the risk of death and improve cardiovascular health in adults.16789

How does the ketogenic and Mediterranean diet treatment for aging differ from other treatments?

The ketogenic diet is unique because it focuses on very low carbohydrate intake, which can lead to weight loss and improved glucose control, while the Mediterranean diet emphasizes a balanced intake of essential nutrients and is associated with prolonged survival, especially in older adults. Both diets offer distinct health benefits, but the Mediterranean diet is more sustainable for long-term use.3491011

Research Team

CB

Cora Best, PhD, RDN

Principal Investigator

University of Florida

Eligibility Criteria

This trial is for older adults who are postmenopausal, have had a stable weight and BMI between 20 to <35 kg/m2 over the past year. Participants must live in a permanent home, be willing to eat provided food, follow dietary advice, document their intake, maintain their current weight, own a smartphone for monitoring purposes and attend study visits.

Inclusion Criteria

I am postmenopausal.
Your weight has not changed much in the past year.
Your body mass index (BMI) must be between 20 and 35.
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
2 visits (in-person), 1 at-home urine collection

Dietary Intervention

Participants are assigned to either a very low carbohydrate ketogenic diet or a Mediterranean diet for 6 weeks. Meals are provided, and participants receive continuous support from a dietitian.

6 weeks
6 visits (in-person, weekly)

Follow-up

Participants are monitored for safety and effectiveness after the dietary intervention

4 weeks

Treatment Details

Interventions

  • Mediterranean Diet
  • Very Low Carbohydrate Ketogenic Diet
Trial Overview The study is testing how two diets affect muscle and bone health in older adults. One group will follow a very low carbohydrate ketogenic diet while another will adhere to a Mediterranean diet. The goal is to see which diet might better prevent muscle decline or impact bone metabolism.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Very low carbohydrate ketogenic diet for six weeksExperimental Treatment1 Intervention
Group II: Mediterranean diet for six weeksActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Florida

Lead Sponsor

Trials
1,428
Recruited
987,000+

Findings from Research

In a study of 183 hospitalized patients over 65 years old, adherence to the Mediterranean diet (MedDiet) was associated with a significant reduction in hospital length of stay by 0.3 days for each unit increase in MedDiet score.
Higher adherence to the MedDiet also correlated with a 13% decrease in long-term mortality risk, suggesting that this dietary pattern not only improves health outcomes but may also reduce healthcare costs.
Effects of Mediterranean diet on hospital length of stay, medical expenses, and mortality in elderly, hospitalized patients: A 2-year observational study.Lampropoulos, CE., Konsta, M., Dradaki, V., et al.[2021]
The Mediterranean Diet (MedDiet) has been linked to numerous health benefits, particularly in reducing the risk of cardiovascular diseases, metabolic disorders, and cancer, as evidenced by an increase in clinical trials over the last decade.
The diet's positive effects are largely attributed to its anti-inflammatory and antioxidant properties, with strict adherence and specific components like olive oil playing crucial roles in managing obesity and waist circumference.
The Mediterranean Diet: An Update of the Clinical Trials.Finicelli, M., Di Salle, A., Galderisi, U., et al.[2022]
In a study of 200 older patients (median age 70) on a ketogenic diet, 67% reported beneficial outcomes, including significant weight loss for 79% of those seeking it, improved glucose control for 54% of those with diabetes, and positive effects on cancer outcomes for 63% of patients pursuing that goal.
While the ketogenic diet showed promise for various health issues in older adults, 15% of participants experienced adverse events, including dyslipidemia and constipation, highlighting the need for careful monitoring in this population.
Can older patients adopt and maintain a ketogenic diet? An observational study in support of clinical trials in older patients.Almodallal, Y., Cook, K., Lammert, LM., et al.[2023]

References

Effects of Mediterranean diet on hospital length of stay, medical expenses, and mortality in elderly, hospitalized patients: A 2-year observational study. [2021]
The Mediterranean Diet: An Update of the Clinical Trials. [2022]
Can older patients adopt and maintain a ketogenic diet? An observational study in support of clinical trials in older patients. [2023]
Low-carbohydrate ketogenic diets in body weight control: A recurrent plaguing issue of fad diets? [2021]
Adherence to the Mediterranean diet in Turkish hospitalized older adults and its association with hospital clinical outcomes. [2022]
A Mediterranean diet supplemented with dairy foods improves markers of cardiovascular risk: results from the MedDairy randomized controlled trial. [2023]
The Mediterranean diet is associated with a reduction in premature mortality among middle-aged adults. [2023]
Including pork in the Mediterranean diet for an Australian population: Protocol for a randomised controlled trial assessing cardiovascular risk and cognitive function. [2019]
Survival beyond age 70 in relation to diet. [2019]
Mediterranean diet and mortality in the elderly: a prospective cohort study and a meta-analysis. [2019]
Are the advantages of the Mediterranean diet transferable to other populations? A cohort study in Melbourne, Australia. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity